Research

New Cancer Drug Makes Commonly Prescribed Chemo Drug More Effective When Given Together


Computer tomography
By Donna Ramirez | June 13, 2017

Researchers have found a way to increase the effectiveness of a widely used cancer drug while decreasing the risk of heart-damaging side effects, according to a new study by researchers from The University of Texas Medical Branch at Galveston and Texas Tech University Health Sciences Center. The findings are currently available in the Journal Scientific Reports Nature publishing group.

UTMB professor Satish Srivastava said that combining a newly-developed drug with a drug used to fight numerous kinds of cancers makes it better suited as a colon cancer treatment. The widely-used drug, doxorubicin, is effective in fighting cancer but can be toxic to the heart when higher doses are needed.

The research, Srivastava said, shows that using aldose reductase inhibitors, an enzyme, when used with doxorubicin, reduces the toxins that can damage the heart.

The researchers have shown earlier that exposure to cancer-causing agents like pollutants triggers oxidative stress, which is a driving source of cancer tissue growth. The oxidative signals are also involved in growing the new blood vessels needed by the cancer tissues. An effort to decrease the oxidative signals is one of the reasons for the popularity of antioxidant-containing foods, beverages, skin care products and vitamins.

“We’ve shown that oxidative signals can be blocked by aldose reductase, or AR, inhibitors,” said lead author Srivastava, who is a professor in UTMB’s departments of biochemistry and molecular biology as well as ophthalmology and visual sciences. “If we could prevent development of the new blood vessels in the cancer tissue driven by these signals, tumor growth and metastasis can be slowed down or prevented.”

The researchers have been using an AR inhibitor called fidarestat to learn how well it prevents growth and metastasis of cancer. The drug has completed Phase II clinical trials in the U.S. and Phase III in Japan for preventing diabetic neuropathy and was found to have no major side effects.

Doxorubicin is commonly prescribed to fight several types of cancers including breast and lung cancers. It is also very cost effective, compared to other cancer drugs. However, colon cancers become resistant to this drug so a higher dosage must be used for it to be effective. The trouble with this is that at higher dosages, it can be toxic to the heart.

“In the study, using human colon cancer cell lines, we showed that the growth of cancer cells can be largely prevented using a combination of both drugs in a petri dish as well as in mouse models,” said Srivastava. “Since doxorubicin is one of the cheapest drugs that is effective against many types of cancer but rarely used in colon cancer, the combination therapy could be highly effective in combating colon cancer while drastically lowering risk of cardiotoxic side effects.”

Srivastava said that since the FDA-approved fidarestat is available through a company in Japan, his eventual goal is to use a combination of fidarestat and doxorubicin to combat various forms of cancer including colon cancer with the hope that combination therapy will require less doxorubicin, which will reduce the potential for toxicity.

Other authors include UTMB’s Himangshu Sonowal, Pabitra Pal, Jian-Jun Wen and Kota Ramana as well as Sanjay Awasthi from Texas Tech University Health Sciences Center. The study was supported by the National Institutes of Health.

Tags | Research



Social Posts

profile_image

BCMHouston

@bcmhouston

RT @LasAmericasMS: TY @bcmhouston medical Stu 4helping our Ss understand Germs &Hygiene. Learning in a new environment &understanding germ…

7 hours ago
profile_image

Houston Methodist

@MethodistHosp

10.26, 6-8 pm: Join @MethodistHosp The Woodlands Hospital for a celebration of women’s health & wellness. Register: https://t.co/3syW4qVpnN

8 hours ago
profile_image

BCMHouston

@bcmhouston

Dr. Janet Malek says increased acceptance of gender nonconformity is raising awareness of intersex issues. https://t.co/svkMN2fdS5

8 hours ago
profile_image

Houston Methodist

houstonmethodist

Join Houston Methodist The Woodlands Hospital for Positively Pink, a celebration of women’s health & wellness. This free event will be held at Big Sky Barn off ...

8 hours ago
profile_image

MD Anderson Cancer Center

MDAnderson

Cancer doesn't care what kind of boots you wear. Join us at MD Anderson Boot Walk to End Cancer on Saturday, Nov. 11 and help give cancer the boot. Register to...

9 hours ago
profile_image

MD Anderson

@MDAndersonNews

@VERONICAGODOY04 Safe travels. Let us know if you need anything while you're here.

9 hours ago
profile_image

MD Anderson

@MDAndersonNews

RT @SurenaMatinMD: Congratulations @ChapinMD for your determination and vision in making this happen #endcancer @MDAndersonNews #ProstateCa…

9 hours ago
profile_image

BCMHouston

@bcmhouston

Tweet #HR4HR to help donate to hurricane relief efforts during the MLB Postseason. https://t.co/291XEy7DqE

9 hours ago
profile_image

MD Anderson

@MDAndersonNews

Find out which #vaccinations cancer patients receiving treatment may need and when it’s best to get them.… https://t.co/7XCJpeJTlg

10 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Retired Army Veteran saw service as an opportunity for education https://t.co/CJjuYulcuB via @bgdailynews

10 hours ago
profile_image

Rice University

@RiceUniversity

https://t.co/s90FB4L6Oj

10 hours ago
profile_image

TexasHeartInstitute

@Texas_Heart

"Not smoking, watching your weight and continuing to learn new things could help you live longer" https://t.co/T79Uuy786i

10 hours ago
profile_image

UTHealth

@UTHealth

RT @McGovernMed: In this week's Study Break, Dean Stoll speaks on team science: https://t.co/PLwJfj4YEG https://t.co/ct46wDXsgc

10 hours ago
profile_image

UTHealth

@UTHealth

RT @McGovernMed: UTHealth, Adult Protective Services join forces to improve lives of Texas elderly https://t.co/QTm8Qhs259

10 hours ago
profile_image

UTHealth

@UTHealth

RT @McGovernMed: Congratulations Dr. Gerard Francisco, elected to #NAM https://t.co/66e3lWXzhQ https://t.co/LaSwcmeYPw

10 hours ago